Tick-borne encephalitis in Japan, Republic of Korea and China

Tick-borne encephalitis virus (TBEV) causes mild or moderate febrile illness in humans that may progress to encephalitis, leading to severe long-term complications and sometimes death. TBEV is prevalent in the Eurasian continent and has been isolated in China, Japan and Republic of Korea (ROK). The...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Emerging microbes & infections Ročník 6; číslo 9; s. e82 - 10
Hlavní autoři:	Yoshii, Kentaro, Song, Joon Young, Park, Seong-Beom, Yang, Junfeng, Schmitt, Heinz-Josef
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Taylor & Francis Ltd 20.09.2017 Nature Publishing Group
Témata:	Animals Asymptomatic Infections - epidemiology China - epidemiology Cost of Illness Encephalitis Encephalitis Viruses, Tick-Borne - immunology Encephalitis Viruses, Tick-Borne - isolation & purification Encephalitis Viruses, Tick-Borne - pathogenicity Encephalitis, Tick-Borne - epidemiology Encephalitis, Tick-Borne - immunology Encephalitis, Tick-Borne - therapy Encephalitis, Tick-Borne - virology Female Humans Japan - epidemiology Male Mice Republic of Korea - epidemiology Review Vaccines Viral Vaccines - immunology South Korea Japan China
ISSN:	2222-1751, 2222-1751
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Tick-borne encephalitis virus (TBEV) causes mild or moderate febrile illness in humans that may progress to encephalitis, leading to severe long-term complications and sometimes death. TBEV is prevalent in the Eurasian continent and has been isolated in China, Japan and Republic of Korea (ROK). The TBEV isolates from Japan are of the Far-Eastern subtype; in ROK, the isolates are of the Western subtype; and all TBEV isolates in China are of the Far-Eastern subtype, except one strain that was identified most recently as the Siberian subtype. TBE is endemic to the northeast, northwest and southeast of China; only two confirmed TBE cases have been reported in Japan to date; and no TBE case has been confirmed in ROK. For TBE patients in China, the onset of disease is acute with no biphasic course for disease presentation. The clinical spectrum of disease phenotypes may be wider than currently understood, since serological evidence suggests the presence of TBEV infections in healthy people, indicating that asymptomatic or unspecific manifestations of TBEV infection may exist. The current treatment for TBE is supportive care. In China, vaccines against TBEV have been developed and are available with demonstrated immunogenicity and safety, although efficacy data are lacking. No vaccines are available in ROK or Japan.
AbstractList	Tick-borne encephalitis virus (TBEV) causes mild or moderate febrile illness in humans that may progress to encephalitis, leading to severe long-term complications and sometimes death. TBEV is prevalent in the Eurasian continent and has been isolated in China, Japan and Republic of Korea (ROK). The TBEV isolates from Japan are of the Far-Eastern subtype; in ROK, the isolates are of the Western subtype; and all TBEV isolates in China are of the Far-Eastern subtype, except one strain that was identified most recently as the Siberian subtype. TBE is endemic to the northeast, northwest and southeast of China; only two confirmed TBE cases have been reported in Japan to date; and no TBE case has been confirmed in ROK. For TBE patients in China, the onset of disease is acute with no biphasic course for disease presentation. The clinical spectrum of disease phenotypes may be wider than currently understood, since serological evidence suggests the presence of TBEV infections in healthy people, indicating that asymptomatic or unspecific manifestations of TBEV infection may exist. The current treatment for TBE is supportive care. In China, vaccines against TBEV have been developed and are available with demonstrated immunogenicity and safety, although efficacy data are lacking. No vaccines are available in ROK or Japan.Tick-borne encephalitis virus (TBEV) causes mild or moderate febrile illness in humans that may progress to encephalitis, leading to severe long-term complications and sometimes death. TBEV is prevalent in the Eurasian continent and has been isolated in China, Japan and Republic of Korea (ROK). The TBEV isolates from Japan are of the Far-Eastern subtype; in ROK, the isolates are of the Western subtype; and all TBEV isolates in China are of the Far-Eastern subtype, except one strain that was identified most recently as the Siberian subtype. TBE is endemic to the northeast, northwest and southeast of China; only two confirmed TBE cases have been reported in Japan to date; and no TBE case has been confirmed in ROK. For TBE patients in China, the onset of disease is acute with no biphasic course for disease presentation. The clinical spectrum of disease phenotypes may be wider than currently understood, since serological evidence suggests the presence of TBEV infections in healthy people, indicating that asymptomatic or unspecific manifestations of TBEV infection may exist. The current treatment for TBE is supportive care. In China, vaccines against TBEV have been developed and are available with demonstrated immunogenicity and safety, although efficacy data are lacking. No vaccines are available in ROK or Japan. Tick-borne encephalitis virus (TBEV) causes mild or moderate febrile illness in humans that may progress to encephalitis, leading to severe long-term complications and sometimes death. TBEV is prevalent in the Eurasian continent and has been isolated in China, Japan and Republic of Korea (ROK). The TBEV isolates from Japan are of the Far-Eastern subtype; in ROK, the isolates are of the Western subtype; and all TBEV isolates in China are of the Far-Eastern subtype, except one strain that was identified most recently as the Siberian subtype. TBE is endemic to the northeast, northwest and southeast of China; only two confirmed TBE cases have been reported in Japan to date; and no TBE case has been confirmed in ROK. For TBE patients in China, the onset of disease is acute with no biphasic course for disease presentation. The clinical spectrum of disease phenotypes may be wider than currently understood, since serological evidence suggests the presence of TBEV infections in healthy people, indicating that asymptomatic or unspecific manifestations of TBEV infection may exist. The current treatment for TBE is supportive care. In China, vaccines against TBEV have been developed and are available with demonstrated immunogenicity and safety, although efficacy data are lacking. No vaccines are available in ROK or Japan. Tick-borne encephalitis virus (TBEV) causes mild or moderate febrile illness in humans that may progress to encephalitis, leading to severe long-term complications and sometimes death. TBEV is prevalent in the Eurasian continent and has been isolated in China, Japan and Republic of Korea (ROK). The TBEV isolates from Japan are of the Far-Eastern subtype; in ROK, the isolates are of the Western subtype; and all TBEV isolates in China are of the Far-Eastern subtype, except one strain that was identified most recently as the Siberian subtype. TBE is endemic to the northeast, northwest and southeast of China; only two confirmed TBE cases have been reported in Japan to date; and no TBE case has been confirmed in ROK. For TBE patients in China, the onset of disease is acute with no biphasic course for disease presentation. The clinical spectrum of disease phenotypes may be wider than currently understood, since serological evidence suggests the presence of TBEV infections in healthy people, indicating that asymptomatic or unspecific manifestations of TBEV infection may exist. The current treatment for TBE is supportive care. In China, vaccines against TBEV have been developed and are available with demonstrated immunogenicity and safety, although efficacy data are lacking. No vaccines are available in ROK or Japan.Emerging Microbes & Infections (2017) 6, e82; doi:10.1038/emi.2017.69; published online 20 September 2017
Author	Yoshii, Kentaro Song, Joon Young Park, Seong-Beom Schmitt, Heinz-Josef Yang, Junfeng
Author_xml	– sequence: 1 givenname: Kentaro surname: Yoshii fullname: Yoshii, Kentaro organization: Laboratory of Public Health, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo 060-0818, Japan – sequence: 2 givenname: Joon Young surname: Song fullname: Song, Joon Young organization: Division of Infectious Diseases, Department of Internal Medicine, Korea University Guro Hospital, Gurodongro 148, Gurogu, Seoul 08308, Republic of Korea – sequence: 3 givenname: Seong-Beom surname: Park fullname: Park, Seong-Beom organization: Pfizer Pharmaceuticals Korea Ltd, Seoul 100-771, Republic of Korea – sequence: 4 givenname: Junfeng surname: Yang fullname: Yang, Junfeng organization: Pfizer Investment Co., Ltd. The Fifth Square, Tower B, 9/F, No. 3-7, Chaoyangmen North Avenue, Dongcheng District, Beijing 100010, China – sequence: 5 givenname: Heinz-Josef surname: Schmitt fullname: Schmitt, Heinz-Josef organization: Scientific Affairs, Pfizer Vaccines Europe, 23-25 Avenue du Dr Lannelongue, Paris 75014, France
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/28928417$$D View this record in MEDLINE/PubMed
BookMark	eNp9kMtLAzEQh4NUbK09eZcFLx7cmmSzeRwUpPguCFLPS5rM2tTdZN2H4H_vilXUg3OZgfn4-M3sooEPHhDaJ3hKcCJPoHRTiomYcrWFRrSvmIiUDH7MQzRpmjXuS2DOCNtBQyoVlYyIETpdOPMcL0PtIQJvoFrpwrWuiZyPbnWl_XH0AFW3LJyJQh7dhRp0pL2NZivn9R7aznXRwGTTx-jx8mIxu47n91c3s_N5vGY0beOlpLnEwCw1YEVi8lxrYJKB0FZhzYxJTQ4UM26s5KAwtVpwwClVzJrUJmN09untk5RgDfi21kVW1a7U9VsWtMt-b7xbZU_hNUs5TROiesHRRlCHlw6aNitdY6AotIfQNRlRjGCVSJz06OEfdB262vfnZTQlXFCacPEf1bs45UriD-rgZ-7vwF__T94BqUSIQg
ContentType	Journal Article
Copyright	Copyright Nature Publishing Group Sep 2017 The Author(s) 2017. This work is licensed under the Creative Commons Attribution License https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Copyright © 2017 The Author(s) 2017 The Author(s)
Copyright_xml	– notice: Copyright Nature Publishing Group Sep 2017 – notice: The Author(s) 2017. This work is licensed under the Creative Commons Attribution License https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Copyright © 2017 The Author(s) 2017 The Author(s)
DBID	CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM
DOI	10.1038/emi.2017.69
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE Publicly Available Content Database Publicly Available Content Database
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Public Health
DocumentTitleAlternate	TBE in Japan, ROK and China
EISSN	2222-1751
EndPage	10
ExternalDocumentID	PMC5625319 28928417
Genre	Journal Article Review
GeographicLocations	South Korea Japan China
GeographicLocations_xml	– name: South Korea – name: Japan – name: China
GroupedDBID	0YH 53G 5VS 7X7 88E 8FI 8FJ AAHBH ABUWG ACGFS ADBBV ADRAZ AENEX AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BENPR BPHCQ BVXVI C6C CCPQU CGR CUY CVF DIK EBS ECGQY ECM EIF EJD EMOBN FYUFA GROUPED_DOAJ HMCUK HYE KQ8 M1P M48 M4Z M~E NAO NPM OK1 PHGZT PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM TDBHL UKHRP 3V. 7XB 8FK AFFHD AZQEC DWQXO K9. PHGZM PJZUB PKEHL PPXIY PQEST PQUKI 7X8 PUEGO 5PM AQTUD
ID	FETCH-LOGICAL-j425t-b82f80e4d2ced73cffaae484e7ad90a4cc5cfe2046cd86e902da76e05294dc5d3
IEDL.DBID	PIMPY
ISICitedReferencesCount	67
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000412088700002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	2222-1751
IngestDate	Tue Nov 04 01:52:17 EST 2025 Fri Sep 05 08:07:35 EDT 2025 Sat Nov 29 14:40:56 EST 2025 Sat Nov 29 15:08:26 EST 2025 Thu Apr 03 07:00:35 EDT 2025
IsDoiOpenAccess	true
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	9
Language	English
License	This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-j425t-b82f80e4d2ced73cffaae484e7ad90a4cc5cfe2046cd86e902da76e05294dc5d3
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23
OpenAccessLink	https://www.proquest.com/publiccontent/docview/2516722367?pq-origsite=%requestingapplication%
PMID	28928417
PQID	1946269807
PQPubID	2041957
PageCount	10
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_5625319 proquest_miscellaneous_1941093803 proquest_journals_2516722367 proquest_journals_1946269807 pubmed_primary_28928417
PublicationCentury	2000
PublicationDate	2017-09-20
PublicationDateYYYYMMDD	2017-09-20
PublicationDate_xml	– month: 09 year: 2017 text: 2017-09-20 day: 20
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States – name: London
PublicationTitle	Emerging microbes & infections
PublicationTitleAlternate	Emerg Microbes Infect
PublicationYear	2017
Publisher	Taylor & Francis Ltd Nature Publishing Group
Publisher_xml	– name: Taylor & Francis Ltd – name: Nature Publishing Group
References	9230360 - J Clin Microbiol. 1997 Aug;35(8):1943-7 21060247 - J Vet Med Sci. 2011 Mar;73(3):409-12 28153343 - Vaccine. 2017 Mar 1;35(9):1227-1237 9615539 - J Med Entomol. 1998 May;35(3):227-31 23590320 - Vector Borne Zoonotic Dis. 2013 Jun;13(6):406-14 23428091 - Vector Borne Zoonotic Dis. 2013 Apr;13(4):215-25 11745938 - J Med Virol. 2001 Dec;65(4):730-5 25311899 - Ticks Tick Borne Dis. 2015 Feb;6(1):38-46 18761916 - Euro Surveill. 2008 Jun 26;13(26):null 18837668 - Vector Borne Zoonotic Dis. 2008 Oct;8(5):713-20 27580555 - Intern Med. 2016;55(17 ):2487-90 27766051 - Thromb J. 2016 Oct 4;14 (Suppl 1):25 23266832 - Arch Virol. 2013 May;158(5):1039-46 11949477 - Jpn J Vet Res. 2002 Feb;49(4):297-307 18755391 - Infect Dis Clin North Am. 2008 Sep;22(3):561-75, x 24394696 - J Gen Virol. 2014 Apr;95(Pt 4):823-35 16540179 - J Virol Methods. 2006 Jun;134(1-2):55-60 24016430 - Zhonghua Liu Xing Bing Xue Za Zhi. 2013 May;34(5):438-42 10195790 - Vaccine. 1999 Mar 17;17(11-12):1532-9 14481659 - Jpn J Med Sci Biol. 1961 Apr;14:51-9 21410387 - N Engl J Med. 2011 Apr 21;364(16):1523-32 1326816 - Virology. 1992 Sep;190(1):515-21 10567643 - J Gen Virol. 1999 Dec;80 ( Pt 12):3127-35 27795275 - Genome Announc. 2016 Oct 20;4(5) 20706026 - J Vet Sci. 2010 Sep;11(3):197-203 10072153 - Am J Trop Med Hyg. 1999 Feb;60(2):287-91 2215376 - Med Parazitol (Mosk). 1990 May-Jun;(3):5-8 27295880 - Bing Du Xue Bao. 2016 Jan;32(1):26-31 25226020 - PLoS One. 2014 Sep 16;9(9):e106798 19239610 - Med Vet Entomol. 2009 Mar;23(1):15-20 18240970 - Vector Borne Zoonotic Dis. 2008 Spring;8(1):7-13 1495032 - J Med Entomol. 1992 Mar;29(2):216-20 25121596 - PLoS Negl Trop Dis. 2014 Aug 14;8(8):e3015 18476578 - Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Dec;28(12):1186-9 27211914 - Ticks Tick Borne Dis. 2016 Jul;7(5):970-978 18179389 - J Infect Dis. 2008 Jan 15;197(2):266-9 17953095 - Emerg Infect Dis. 2007 Aug;13(8):1215-8 21290821 - Mol Biol (Mosk). 2010 Nov-Dec;44(6):985-93 9499069 - J Virol. 1998 Mar;72(3):2132-40 22497964 - Int J Infect Dis. 2012 Jun;16(6):e448-52 22309667 - Expert Rev Vaccines. 2012 Feb;11(2):177-87 21900425 - J Gen Virol. 2011 Dec;92(Pt 12):2821-9 24159517 - Osong Public Health Res Perspect. 2012 Dec;3(4):213-21 16957192 - Appl Environ Microbiol. 2006 Sep;72(9):5766-76 18445446 - Euro Surveill. 2008 Apr 24;13(17):null 27776187 - PLoS One. 2016 Oct 24;11(10 ):e0165207 26073735 - Jpn J Infect Dis. 2016;69(2):131-4 22004565 - Microbiol Immunol. 2011 Dec;55(12):893-7 10067683 - Vaccine. 1999 Feb 26;17(7-8):779-87 26969490 - Ticks Tick Borne Dis. 2016 Jul;7(5):723-729 21050126 - J Infect Dis. 2010 Dec 15;202(12 ):1813-8 19420159 - J Gen Virol. 2009 Aug;90(Pt 8):1781-94 20707897 - Int J Health Geogr. 2010 Aug 13;9:42
References_xml	– reference: 18445446 - Euro Surveill. 2008 Apr 24;13(17):null – reference: 1495032 - J Med Entomol. 1992 Mar;29(2):216-20 – reference: 18837668 - Vector Borne Zoonotic Dis. 2008 Oct;8(5):713-20 – reference: 20707897 - Int J Health Geogr. 2010 Aug 13;9:42 – reference: 22497964 - Int J Infect Dis. 2012 Jun;16(6):e448-52 – reference: 16540179 - J Virol Methods. 2006 Jun;134(1-2):55-60 – reference: 19420159 - J Gen Virol. 2009 Aug;90(Pt 8):1781-94 – reference: 24016430 - Zhonghua Liu Xing Bing Xue Za Zhi. 2013 May;34(5):438-42 – reference: 18755391 - Infect Dis Clin North Am. 2008 Sep;22(3):561-75, x – reference: 27580555 - Intern Med. 2016;55(17 ):2487-90 – reference: 16957192 - Appl Environ Microbiol. 2006 Sep;72(9):5766-76 – reference: 23428091 - Vector Borne Zoonotic Dis. 2013 Apr;13(4):215-25 – reference: 10195790 - Vaccine. 1999 Mar 17;17(11-12):1532-9 – reference: 2215376 - Med Parazitol (Mosk). 1990 May-Jun;(3):5-8 – reference: 10072153 - Am J Trop Med Hyg. 1999 Feb;60(2):287-91 – reference: 11745938 - J Med Virol. 2001 Dec;65(4):730-5 – reference: 22309667 - Expert Rev Vaccines. 2012 Feb;11(2):177-87 – reference: 21050126 - J Infect Dis. 2010 Dec 15;202(12 ):1813-8 – reference: 1326816 - Virology. 1992 Sep;190(1):515-21 – reference: 21900425 - J Gen Virol. 2011 Dec;92(Pt 12):2821-9 – reference: 18240970 - Vector Borne Zoonotic Dis. 2008 Spring;8(1):7-13 – reference: 9499069 - J Virol. 1998 Mar;72(3):2132-40 – reference: 27295880 - Bing Du Xue Bao. 2016 Jan;32(1):26-31 – reference: 23590320 - Vector Borne Zoonotic Dis. 2013 Jun;13(6):406-14 – reference: 10567643 - J Gen Virol. 1999 Dec;80 ( Pt 12):3127-35 – reference: 18761916 - Euro Surveill. 2008 Jun 26;13(26):null – reference: 18179389 - J Infect Dis. 2008 Jan 15;197(2):266-9 – reference: 9615539 - J Med Entomol. 1998 May;35(3):227-31 – reference: 26969490 - Ticks Tick Borne Dis. 2016 Jul;7(5):723-729 – reference: 25121596 - PLoS Negl Trop Dis. 2014 Aug 14;8(8):e3015 – reference: 9230360 - J Clin Microbiol. 1997 Aug;35(8):1943-7 – reference: 20706026 - J Vet Sci. 2010 Sep;11(3):197-203 – reference: 22004565 - Microbiol Immunol. 2011 Dec;55(12):893-7 – reference: 21060247 - J Vet Med Sci. 2011 Mar;73(3):409-12 – reference: 24159517 - Osong Public Health Res Perspect. 2012 Dec;3(4):213-21 – reference: 25311899 - Ticks Tick Borne Dis. 2015 Feb;6(1):38-46 – reference: 28153343 - Vaccine. 2017 Mar 1;35(9):1227-1237 – reference: 27766051 - Thromb J. 2016 Oct 4;14 (Suppl 1):25 – reference: 18476578 - Zhonghua Liu Xing Bing Xue Za Zhi. 2007 Dec;28(12):1186-9 – reference: 14481659 - Jpn J Med Sci Biol. 1961 Apr;14:51-9 – reference: 19239610 - Med Vet Entomol. 2009 Mar;23(1):15-20 – reference: 10067683 - Vaccine. 1999 Feb 26;17(7-8):779-87 – reference: 11949477 - Jpn J Vet Res. 2002 Feb;49(4):297-307 – reference: 27795275 - Genome Announc. 2016 Oct 20;4(5): – reference: 23266832 - Arch Virol. 2013 May;158(5):1039-46 – reference: 24394696 - J Gen Virol. 2014 Apr;95(Pt 4):823-35 – reference: 25226020 - PLoS One. 2014 Sep 16;9(9):e106798 – reference: 27776187 - PLoS One. 2016 Oct 24;11(10 ):e0165207 – reference: 21410387 - N Engl J Med. 2011 Apr 21;364(16):1523-32 – reference: 27211914 - Ticks Tick Borne Dis. 2016 Jul;7(5):970-978 – reference: 26073735 - Jpn J Infect Dis. 2016;69(2):131-4 – reference: 17953095 - Emerg Infect Dis. 2007 Aug;13(8):1215-8 – reference: 21290821 - Mol Biol (Mosk). 2010 Nov-Dec;44(6):985-93
SSID	ssj0000706414
Score	2.3950202
SecondaryResourceType	review_article
Snippet	Tick-borne encephalitis virus (TBEV) causes mild or moderate febrile illness in humans that may progress to encephalitis, leading to severe long-term...
SourceID	pubmedcentral proquest pubmed
SourceType	Open Access Repository Aggregation Database Index Database
StartPage	e82
SubjectTerms	Animals Asymptomatic Infections - epidemiology China - epidemiology Cost of Illness Encephalitis Encephalitis Viruses, Tick-Borne - immunology Encephalitis Viruses, Tick-Borne - isolation & purification Encephalitis Viruses, Tick-Borne - pathogenicity Encephalitis, Tick-Borne - epidemiology Encephalitis, Tick-Borne - immunology Encephalitis, Tick-Borne - therapy Encephalitis, Tick-Borne - virology Female Humans Japan - epidemiology Male Mice Republic of Korea - epidemiology Review Vaccines Viral Vaccines - immunology
Title	Tick-borne encephalitis in Japan, Republic of Korea and China
URI	https://www.ncbi.nlm.nih.gov/pubmed/28928417 https://www.proquest.com/docview/1946269807 https://www.proquest.com/docview/2516722367 https://www.proquest.com/docview/1941093803 https://pubmed.ncbi.nlm.nih.gov/PMC5625319
Volume	6
WOSCitedRecordID	wos000412088700002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2222-1751 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000706414 issn: 2222-1751 databaseCode: DOA dateStart: 20120101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2222-1751 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000706414 issn: 2222-1751 databaseCode: M~E dateStart: 20120101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2222-1751 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000706414 issn: 2222-1751 databaseCode: 7X7 dateStart: 20120701 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 2222-1751 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000706414 issn: 2222-1751 databaseCode: BENPR dateStart: 20120701 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 2222-1751 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000706414 issn: 2222-1751 databaseCode: PIMPY dateStart: 20120701 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAWR databaseName: Taylor & Francis Open Access customDbUrl: eissn: 2222-1751 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000706414 issn: 2222-1751 databaseCode: 0YH dateStart: 20140101 isFulltext: true titleUrlDefault: https://www.tandfonline.com providerName: Taylor & Francis
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Nb9MwFH9i7Q6TJj7GBoVRGYnjvDqJE9sHhAB14kNU1TSk7lQ5_lAzNKesK38_z0lW2DRx4pKL48jx-35-_j2AN6jijFRO0URkJeXcl7RMuaZpYYzPpbMsKZtmE2IykbOZmnbXo1ddWeWNTmwUdYv2HOu2UQmPbG1ixnyEVrkQaUQfe7f8SWMPqXjW2jXU2IJ-BN5iPehPP3-bnm9yLsjeBU94d02PZXLkLqtY3iWOi3tdzLuVkn-ZnpNH_3fRj-Fh54KS9y3PPIEHLuzBbpu_I-21pKfw9qwyPygySHAkCv9yER32akWqQL6ggQ1H5NS1CyC1J19rdD6JDpY0Dbn34fvJ-OzjJ9q1WqAXKLTXtJSpl8xxmxpnRWa819pxyZ3QVjHNjcmNdykG08bKwimWWi0KF48JuTW5zQ6gF-rgngMRZWKR5HnmS8Ex_lS59wr_WgkthVDlAA5v9mreyctqniiOkZWSTNw7_GfnBvB6M4yCEE83dHD1uvlEhMaSLBvAs5Zq82WL2DHHqBLNcIKzxS16bl6IINu3R0K1aMC2Y4CIaurFv5f1EnYiG8VCkpQdQu_6au1ewbb5hYS5GsKWmInmKYfQ_zCeTE-HTfA_7Dj0N31w9WQ
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLRJIiPdjoYCR4Iap4zixfagQAqou265WaJHaU0j8UAPCWbotiD_Fb2ScZBeKKm49cHYySjzfjOezxzMAT9HFGaWdpolMKyqEr2jFRUl5bozPlLMsqdpmE3IyUfv7eroGP5d3YWJa5dInto7aNibukW_iOpxLHuuNvZx_pbFrVDxdXbbQ6GAxdj--I2VbbI3eoH6fcb79dvZ6h_ZdBegnxOcxrRT3ijlhuXFWpsb7snRCCSdLq1kpjMmMdxx5o7Eqd5pxW8rcxRMxYU1mU5R7AdYFCmMDWJ-O9qYHq10dNKBcJKK_CMhStem-1DGBTL7Izwxi_87F_GNx2772v03Ldbjah9HkVYf7G7Dmwk240u1Bku5q1S3YmtXmM0WQB0eiA5sfRtJRL0gdyDsMEsJz8t51db5J48m4wQCalMGStqn4bfhwLn9wBwahCe4eEFklFmGbpb6SAjm0zrzXOMtalkpKXQ1hY6mNorf5RZFogexQKybPHP6tqSE8WQ2jMccTmjK45qQVEct7KZYO4W6Hi2LeVR0pkBljKJHg2_IUYlYPxELhp0dCfdgWDI8kF13t_X9_1mO4tDPb2y12R5PxA7gcQRsTYzjbgMHx0Yl7CBfNN1TS0aMe9QQ-njeifgFpckZO
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Tick-borne+encephalitis+in+Japan%2C+Republic+of+Korea+and+China&rft.jtitle=Emerging+microbes+%26+infections&rft.au=Yoshii%2C+Kentaro&rft.au=Song%2C+Joon+Young&rft.au=Park%2C+Seong-Beom&rft.au=Yang%2C+Junfeng&rft.date=2017-09-20&rft.eissn=2222-1751&rft.volume=6&rft.issue=9&rft.spage=e82&rft_id=info:doi/10.1038%2Femi.2017.69&rft_id=info%3Apmid%2F28928417&rft.externalDocID=28928417
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2222-1751&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2222-1751&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2222-1751&client=summon